Robert Kemp

927 total citations
45 papers, 635 citations indexed

About

Robert Kemp is a scholar working on Epidemiology, Toxicology and Pharmacology. According to data from OpenAlex, Robert Kemp has authored 45 papers receiving a total of 635 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 7 papers in Toxicology and 6 papers in Pharmacology. Recurrent topics in Robert Kemp's work include HIV, Drug Use, Sexual Risk (10 papers), Substance Abuse Treatment and Outcomes (8 papers) and Forensic Toxicology and Drug Analysis (7 papers). Robert Kemp is often cited by papers focused on HIV, Drug Use, Sexual Risk (10 papers), Substance Abuse Treatment and Outcomes (8 papers) and Forensic Toxicology and Drug Analysis (7 papers). Robert Kemp collaborates with scholars based in Australia, United States and United Kingdom. Robert Kemp's co-authors include Vinay Prasad, Jake M. Najman, Andrew Smirnov, Xiaojun Wang, A. Dale Magoun, Helene Wells, Chenghui Li, Kyle Crowder, Julian Casciano and Liam Downey and has published in prestigious journals such as The Lancet, Critical Care Medicine and Journal of Marriage and the Family.

In The Last Decade

Robert Kemp

43 papers receiving 605 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Kemp Australia	14	173	103	87	84	75	45	635
Manuel Espinoza Chile	16	211 1.2×	203 2.0×	43 0.5×	115 1.4×	163 2.2×	101	943
Jean‐Paul Fagot France	16	276 1.6×	64 0.6×	31 0.4×	63 0.8×	47 0.6×	23	1.6k
Azadeh Safaee Iran	20	158 0.9×	58 0.6×	295 3.4×	82 1.0×	79 1.1×	74	1.4k
S. Mulla Canada	6	145 0.8×	74 0.7×	88 1.0×	194 2.3×	50 0.7×	9	954
Karen Kim United States	17	153 0.9×	36 0.3×	113 1.3×	169 2.0×	154 2.1×	78	1.1k
Charlton Wilson United States	22	270 1.6×	66 0.6×	136 1.6×	127 1.5×	160 2.1×	47	1.4k
Johan Jarl Sweden	17	204 1.2×	104 1.0×	37 0.4×	123 1.5×	154 2.1×	61	753
Eli J. Korner United States	11	136 0.8×	108 1.0×	28 0.3×	65 0.8×	88 1.2×	20	651
Willem M. van der Wal Netherlands	12	134 0.8×	64 0.6×	158 1.8×	50 0.6×	44 0.6×	15	751
Meenal Patwardhan United States	16	185 1.1×	178 1.7×	86 1.0×	193 2.3×	155 2.1×	37	1.2k

Countries citing papers authored by Robert Kemp

Since Specialization

Citations

This map shows the geographic impact of Robert Kemp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Kemp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Kemp more than expected).

Fields of papers citing papers by Robert Kemp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Kemp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Kemp. The network helps show where Robert Kemp may publish in the future.

Co-authorship network of co-authors of Robert Kemp

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Kemp. A scholar is included among the top collaborators of Robert Kemp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Kemp. Robert Kemp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Maher, Lisa, Handan Wand, Robert Kemp, et al.. (2024). Utilising integrated bio-behavioural surveillance (IBBS) to investigate declining hepatitis C antibody prevalence among people who inject drugs in the Australian Needle and Syringe Program Survey. International Journal of Drug Policy. 144(Pt 1). 104576–104576.

Kemp, Robert, et al.. (2021). Relationship between FEV1 decline and mortality in patients with bronchiolitis obliterans syndrome—a systematic literature review. Respiratory Medicine. 188. 106608–106608. 4 indexed citations

Cherney, Adrian, et al.. (2018). Experiences of police contact among young adult recreational drug users: A qualitative study. International Journal of Drug Policy. 56. 64–72. 4 indexed citations

Jacka, Brendan, Amy Peacock, Louisa Degenhardt, et al.. (2017). Trends in PIEDs use among male clients of needle–syringe programs in Queensland, Australia; 2007–2015. International Journal of Drug Policy. 46. 74–78. 11 indexed citations

Smirnov, Andrew, et al.. (2017). Simultaneous use of alcohol with methamphetamine but not ecstasy linked with aggression among young adult stimulant users. Addictive Behaviors. 70. 27–34. 18 indexed citations

Najman, Jake M., et al.. (2017). When Knowledge and Experience Do Not Help: A Study of Nonfatal Drug Overdoses. Journal of Addiction Medicine. 11(4). 280–285. 5 indexed citations

Kemp, Robert & Vinay Prasad. (2017). Surrogate endpoints in oncology: when are they acceptable for regulatory and clinical decisions, and are they currently overused?. BMC Medicine. 15(1). 134–134. 173 indexed citations

Casciano, Julian, Jerry A. Krishnan, Mary Buatti Small, et al.. (2016). Burden of asthma with elevated blood eosinophil levels. BMC Pulmonary Medicine. 16(1). 100–100. 25 indexed citations

Casciano, Julian, Jerry A. Krishnan, Mary Buatti Small, et al.. (2016). Value of peripheral blood eosinophil markers to predict severity of asthma. BMC Pulmonary Medicine. 16(1). 109–109. 25 indexed citations

10.

Kemp, Robert, et al.. (2014). Factors associated with medication adherence and persistence of treatment for hypertension in a Medicaid population. Research in Social and Administrative Pharmacy. 10(6). e99–e112. 45 indexed citations

11.

Kemp, Robert. (2014). Remember the MaineRx. Applied Health Economics and Health Policy. 12(1). 1–5. 2 indexed citations

12.

Smirnov, Andrew, et al.. (2013). Young adults' trajectories of Ecstasy use: A population based study. Addictive Behaviors. 38(11). 2667–2674. 15 indexed citations

13.

Fischer, Gabriele, et al.. (2013). Quality of life of people who inject drugs: characteristics and comparisons with other population samples. Quality of Life Research. 22(8). 2113–2121. 25 indexed citations

14.

Rogers, Richard G., Patrick M. Krueger, Richard A. Miech, Elizabeth Lawrence, & Robert Kemp. (2013). Nondrinker Mortality Risk in the United States. Population Research and Policy Review. 32(3). 325–352. 18 indexed citations

15.

Smirnov, Andrew & Robert Kemp. (2012). Use and Misuse of Opioid Replacement Therapies: A Queensland Study. Substance Use & Misuse. 47(1). 78–85. 6 indexed citations

16.

Brunton, Cheryl, et al.. (2000). Cumulative incidence of hepatitis C seroconversion in a cohort of seronegative injecting drug users.. PubMed. 113(1106). 98–101. 18 indexed citations

17.

Robinson, Geoffrey, Robert Kemp, Colin Lee, & David Cranston. (2000). Patients in methadone maintenance treatment who inject methadone syrup: a preliminary study. Drug and Alcohol Review. 19(4). 447–450. 8 indexed citations

18.

Ballachanda, Bopanna B., Ross J. Roeser, & Robert Kemp. (1996). Control and Prevention of Disease Transmission in Audiology Practice. American Journal of Audiology. 5(1). 74–82. 1 indexed citations

19.

Kemp, Robert. (1996). Australia's "free-ride" in pharmaceuticals: Can it last?. Australian Health Review. 19(1). 81–94. 3 indexed citations

20.

Coetzee, David & Robert Kemp. (1982). Community-based rehabilitation in the service area of Stikland Hospital--the problem defined.. PubMed. 61(20). 751–4. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact